|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：R418100 |
| 產(chǎn)品名稱：RIDK34 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：25mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
R418100 |
| 名稱: |
RIDK34 |
| 別名: |
(E)-12,14-Dihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde oxime |
| 分子式: |
C??H??NO?? |
| 分子量: |
565.65 |
| 類別: |
Standards; Steroids; |
| 應(yīng)用: |
RIDK34 is a possible cardiac glycosides (CG) analogue with higher potency and displays lower relative inhibition of Na+/K+-ATPase activity. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
